[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B]

S Suárez Ortega1, M I Campos-Herrero Navas, M A Limeres González

  • 1Servicio de Medicina Interna, Hospital General de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria. drsuarez@hotmail.com

Anales De Medicina Interna (Madrid, Spain : 1984)
|June 16, 2004
PubMed

Insights

A 75-year-old woman with antiphospholipid-antibody syndrome developed a rare Aspergillus terreus lung infection. Prompt treatment with liposomal Amphotericin B led to a favorable outcome, contrasting with typical high mortality rates.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Rheumatology

Background:

  • Antiphospholipid-antibody syndrome (APS) is an autoimmune disorder associated with an increased risk of thrombosis and pregnancy complications.
  • Overlap syndrome, particularly when associated with APS, presents complex diagnostic and therapeutic challenges.

Observation:

  • A 75-year-old female patient presented with lower limb weakness and neurological deficits.
  • Radiological imaging revealed vertebral fractures, suspected discitis, and bilateral pulmonary infiltrates with cavitation.
  • Fungal elements identified in lung biopsy and Aspergillus terreus confirmed in bronchial washings.

Findings:

  • The patient was diagnosed with an overlap syndrome associated with antiphospholipid-antibody syndrome.
  • Pulmonary Aspergillus terreus infection was successfully treated with liposomal Amphotericin B followed by oral Itraconazole.
  • High IgM anticardiolipin antibody (ACA) titers were noted, exceeding those previously reported in literature.

Implications:

  • This case highlights the unusual presentation and successful management of Aspergillus terreus pneumonia in an immunocompetent patient with APS.
  • The findings underscore the importance of considering opportunistic infections in patients with autoimmune disorders.
  • The favorable response to liposomal Amphotericin B contrasts with literature reporting high mortality for invasive aspergillosis.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...